Archive for the ‘Bone Mineral Metabolism’ Category

May 1, 2010

Oral Phosphate Binders in Patients with Kidney Failure

.   .   

This concise review discusses the rationale for the use of phosphate binders in kidney disease and summarizes therapeutic strategies.

1 Comment Posted in Bone Mineral Metabolism, Review
February 12, 2010

Second Chances in Mineral Metabolism

.   .   

In this succinct editorial, Dr. Wolf reinforces the rationale for performing proper randomized controlled trials in bone mineral metabolism before changing clinical practice.  In addition, he provides insight into a first-in-class substudy of the ACHIEVE study which looks at the effects of cinacalcet and activated Vitamin D on FGF23 levels in ESRD. Free full text […]

1 Comment Posted in Bone Mineral Metabolism
August 21, 2009

KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD)

These clinical practice guidelines developed by KDIGO are designed to address the diagnosis, evaluation, prevention and treatment of CKD related disorders of bone mineral metabolism.

1 Comment Posted in Bone Mineral Metabolism, Clinical Practice Guidelines, Vascular Disease/Calcification
March 1, 2009

Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.

.   .   

1 Comment Posted in Bone Mineral Metabolism
March 1, 2009

Salivary phosphorus binding: a novel approach to control hyperphosphatemia.

.   .   

Comments Off on Salivary phosphorus binding: a novel approach to control hyperphosphatemia. Posted in Bone Mineral Metabolism
March 1, 2009

Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial.

.   .   

Comments Off on Effect of Food Additives on Hyperphosphatemia Among Patients With End-stage Renal Disease A Randomized Controlled Trial. Posted in Bone Mineral Metabolism
November 1, 2008

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

.   .   

Comments Off on Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. Posted in Bone Mineral Metabolism
October 1, 2008

Oral active vitamin D is associated with improved survival in hemodialysis patients.

.   .   

Comments Off on Oral active vitamin D is associated with improved survival in hemodialysis patients. Posted in Bone Mineral Metabolism
October 1, 2008

Vitamin D in chronic kidney disease: is the jury in?

.   .   

Comments Off on Vitamin D in chronic kidney disease: is the jury in? Posted in Bone Mineral Metabolism
August 1, 2008

Association of oral calcitriol with improved survival in nondialyzed CKD.

.   .   

Comments Off on Association of oral calcitriol with improved survival in nondialyzed CKD. Posted in Bone Mineral Metabolism
August 1, 2008

Active vitamin D and survival.

.   .   

Comments Off on Active vitamin D and survival. Posted in Bone Mineral Metabolism
July 1, 2008

A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.

.   .   

Comments Off on A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Posted in Bone Mineral Metabolism
July 1, 2008

Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.

.   .   

Comments Off on Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease. Posted in Bone Mineral Metabolism